These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30045738)

  • 1. Civil society in global health policymaking: a critical review.
    Gómez EJ
    Global Health; 2018 Jul; 14(1):73. PubMed ID: 30045738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factoring civil society actors into health policy processes in low- and middle-income countries: a review of research articles, 2007-16.
    Smith SL
    Health Policy Plan; 2019 Feb; 34(1):67-77. PubMed ID: 30668676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How donors support civil society as government accountability advocates: a review of strategies and implications for transition of donor funding in global health.
    McDonough A; Rodríguez DC
    Global Health; 2020 Nov; 16(1):110. PubMed ID: 33183333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing our understanding of the commercial determinants of health: Theories, methods, and insights from political science.
    Gómez EJ
    Soc Sci Med; 2022 May; 301():114931. PubMed ID: 35358943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Civil society participation in global public private partnerships for health.
    Storeng KT; de Bengy Puyvallée A
    Health Policy Plan; 2018 Oct; 33(8):928-936. PubMed ID: 30165606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring health researchers' perceptions of policymaking in Argentina: a qualitative study.
    Corluka A; Hyder AA; Winch PJ; Segura E
    Health Policy Plan; 2014 Sep; 29 Suppl 2(Suppl 2):ii40-9. PubMed ID: 25274639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advocacy counterstrategies to tobacco industry interference in policymaking: a scoping review of peer-reviewed literature.
    Matthes BK; Kumar P; Dance S; Hird T; Carriedo Lutzenkirchen A; Gilmore AB
    Global Health; 2023 Jun; 19(1):42. PubMed ID: 37344818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pitfalls of Ascribing Moral Agency to Corporations: Public Obligation and Political and Social Contexts in the Commercial Determinants of Health.
    Gómez EJ; Maani N; Galea S
    Milbank Q; 2024 Mar; 102(1):28-42. PubMed ID: 37880820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research, evidence and policymaking: the perspectives of policy actors on improving uptake of evidence in health policy development and implementation in Uganda.
    Orem JN; Mafigiri DK; Marchal B; Ssengooba F; Macq J; Criel B
    BMC Public Health; 2012 Feb; 12():109. PubMed ID: 22316003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agenda setting and socially contentious policies: Ethiopia's 2005 reform of its law on abortion.
    Holcombe SJ; Kidanemariam Gebru S
    Reprod Health; 2022 Jun; 19(Suppl 1):218. PubMed ID: 35698196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Civil society advocacy in Nigeria: promoting democratic norms or donor demands?
    Williamson RT; Rodd J
    BMC Int Health Hum Rights; 2016 Jul; 16(1):19. PubMed ID: 27400871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Civil society demand for accountability to achieve the 90-90-90 targets: lessons from Eastern and Southern Africa.
    Russell A; Luba M; Mwehonge K; Lusimbo R; Milanga M; Kavanagh MM
    Curr Opin HIV AIDS; 2019 Jan; 14(1):41-45. PubMed ID: 30480584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the process of evidence-informed health policymaking in Bangladesh: a systematic review.
    Dodd M; Ivers R; Zwi AB; Rahman A; Jagnoor J
    Health Policy Plan; 2019 Jul; 34(6):469-478. PubMed ID: 31237941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Civil society's role in improving hypertension control in Latin America.
    Champagne BM; Antonio Ochoa E; Khanchandani HS; Schoj V
    Rev Panam Salud Publica; 2022; 46():e165. PubMed ID: 36128471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing evidence use in public health nutrition policymaking: theoretical insights from a New Zealand case study.
    Field P; Gauld R; Lawrence M
    Health Res Policy Syst; 2016 Nov; 14(1):84. PubMed ID: 27887613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of education equity policy in a COVID-19 world: a qualitative systematic review of lessons from education policymaking.
    Cairney P; Kippin S
    Open Res Eur; 2021; 1():78. PubMed ID: 37645089
    [No Abstract]   [Full Text] [Related]  

  • 17. Constituent-driven health policy informed by policy advocacy literature.
    Figueroa R; Verma R
    Transl Behav Med; 2023 May; 13(5):338-342. PubMed ID: 36694934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based policymaking is not like evidence-based medicine, so how far should you go to bridge the divide between evidence and policy?
    Cairney P; Oliver K
    Health Res Policy Syst; 2017 Apr; 15(1):35. PubMed ID: 28446185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Civil society involvement in harm reduction drug policy: reflections on the past, expectations for the future.
    O'Gorman A; Schatz E
    Harm Reduct J; 2021 Feb; 18(1):17. PubMed ID: 33568156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The making of nursing practice law in Lebanon: a policy analysis case study.
    El-Jardali F; Hammoud R; Younan L; Nuwayhid HS; Abdallah N; Alameddine M; Bou-Karroum L; Salman L
    Health Res Policy Syst; 2014 Sep; 12():52. PubMed ID: 25193112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.